CDC Logo Tuberculosis Information CD-ROM   Image of people
     
jump over main navigation bar to content area
Home
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Newsletters
Ordering Information
Help

 

U.S. Department of Health and Human Services

  
jump over right navigation bar
TB Notes 1, 2000
Introduction
Where We've Been and Where We're Going: Perspectives from CDC's Partners in TB Control
Changes I've Seen
TB Control in New York City: A Recent History
Not by DOT Alone
Baltimore at the New Millennium
From Crickets to Condoms and Beyond
The Denver TB Program: Opportunity, Creativity, Persistence, and Luck
National Jewish: The 100-Year War Against TB
Earthquakes, Population Growth, and TB in Los Angeles County
TB in Alaska
CDC and the American Lung Association/ American Thoracic Society: an Enduring Public/Private Partnership
The Unusual Suspects
The Model TB Prevention and Control Centers: History and Purpose
My Perspective on TB Control over the Past Two to Three Decades
History of the IUATLD
Thoughts about the Future of TB Control in the United States
Where We've Been and Where We're Going: Perspectives from CDC
Early History of the CDC TB Division, 1944-1985
CDC Funding for TB Prevention and Control
Managed Care and TB Control - A New Era
Early Research Activities of the TB Control Division
The First TB Drug Clinical Trials
Current TB Drug Trials: The Tuberculosis Trials Consortium (TBTC)
TB Communications and Education
TB Control in the Information Age
Field Services Activities
TB's Public Health Heroes
Infection Control Issues
A Decade of Notable TB Outbreaks: A Selected Review
International Activities
The Role of CDC's Division of Quarantine in the Fight Against TB in the U.S.
The STOP TB Initiative, A Global Partnership
Seize the Moment - Personal Reflections
 
Return to Table of Contents

This is an archived document. The links are no longer being updated.

TB Notes 1, 2000

A Glimpse at the Colorful History of TB: Its Toll and Its Effect on the U.S. and the World

by Dan Ruggiero
Division of TB Elimination

In their 1969 book Tuberculosis, Lowell et al. tell us that "Tuberculosis is an ancient disease with a lineage that can be traced to the earliest history of mankind…In the last millennium it has been universally distributed among all branches of the human race."

Phthisis (from the Greek word 'to waste away'), scrofula (swellings of the lymph nodes of the neck), the white plague (the TB epidemic in Europe during the 18th century), consumption (progressive wasting away of the body), TB (the presence or products of the tubercle bacillus) are all words for tuberculosis marking a specific point in history. Each has a significant connotation and meaning to millions of people about a disease that has afflicted humans from the dawn of history and continues to ravage mankind in large numbers. During World TB Day 1999 it was reported that an estimated one billion persons died of the disease worldwide during the 19th and early 20th centuries alone. This invisible enemy continues to challenge man's knowledge and mock his efforts; the "Captain of the men of death" continues to march forth leaving behind a trail of human misery, economic chaos, and death. What is the origin of this invisible predator that even today has been able to adapt and survive by fending off the many remedies and cures that the best minds in science have placed before it?

The tubercle bacillus, the organism that causes TB disease, can be traced as far back as 5000 BC when archeologists found evidence in human bones of the existence of TB. Evidence was found in ancient Egyptian mummies which showed deformities consistent with TB disease. Paleontologists have concluded that the disease must have been prevalent in that part of the civilized world.

Image 1: Photograph showing evidence of TB in ancient human bone, showing deformities consistent with TB disease.

Evidence of TB appears in Biblical scripture, in Chinese literature dating back to around 4000 BC, and in religious books in India around 2000 BC. In ancient Greece Hippocrates mentions TB around 400 BC, as does Aristotle, who talked about "phthisis and its cure" (ca. 350 BC).

It was widely believed that European explorers, sailors, and the settlers who followed Columbus to the new world brought with them many infectious diseases, among them TB. However, paleopathologists suspected that TB existed in the New World before 1492, based on ancient skeletons and bones that contained lesions resembling those caused by TB. Evidence to that effect was found in 1994, when scientists reported that they had identified TB bacterium DNA in the mummified remains of a woman who had died in the Americas 500 years before Columbus set sail for the New World.

The TB epidemic in Europe that came to be called the "Great White Plague" probably started in the early 1600s and continued for the next 200 years. The epidemic reached its peak in western Europe 12, and in the United States in the late 1700s and early 1800s. In early 19th century England, TB was so pervasive a killer that it dwarfed other dreaded diseases like cholera and typhus. So common and so little understood was TB that death from the disease was accepted as inevitable. TB in the early 19th century may have accounted for one third of all deaths. Death from TB was clearly evident in the literature of the time in the writings of John Keats (1795-1821) in the Ode to a Nightingale, of John Bunyan (1628-1688) in The Life and Death of Mr. Badman, of Charles Dickens (1812-1870) in Nicholas Nickleby, and of other famous writers of the time.

In 1720, in his publication, A New Theory of Consumption, the English physician Benjamin Marten was the first to conjecture that TB could be caused by "wonderfully minute living creatures," which, once they had gained a foothold in the body, could generate the lesions and symptoms of the disease. He continued that "It may be therefore very likely that by an habitual lying in the same bed with a consumptive patient, constantly eating and drinking with him, or by very frequently conversing so nearly as to draw in part of the breath he emits from the Lungs, a consumption may be caught by a sound person…I imagine that slightly conversing with consumptive patients is seldom or never sufficient to catch the disease." For a physician living in such an early era, Dr. Marten showed much medical insight.

Image 2:Photo of Dr. Robert Koch, who in 1882 presented to the scientific community his discovery of the organism that causes TB.

In 1882, at a time when TB was raging through Europe and the Americas, killing one in seven people, a German biologist by the name of Robert Koch presented to the scientific community his discovery of the organism that caused TB. It was called a tubercle bacillus because small rounded bodies (tubercles) occurred in the diseased tissue and were characteristic of the disease. Through his many experiments with the organism, Dr. Koch worked on developing a cure for TB. Koch was able to isolate a protein from the tubercle bacillus that he tried as an immunizing agent and later as a treatment for TB; in both cases it failed. However, the substance, now called "old tuberculin," was to be later used as the screening tool (tuberculin skin tests) for identifying people and animals infected with tubercle bacilli.

A further significant advance came in 1895 when Wilhelm Konrad von Roentgen discovered the radiation that bears his name. This allowed the progress and severity of a patient's disease to be accurately followed and reviewed.

Another important development was provided by the French bacteriologist Calmette. Together with Guerin, he used specific culture media to lower the virulence of the bovine TB bacterium, thus creating the basis for the BCG vaccine still in widespread use today.

TB in America during the colonial period was accepted as a scourge of humanity that was common to the poor and rich alike. The first available mortality figures from Massachusetts in 1786 indicated 300 deaths per 100,000 population. The peak mortality figure reached in New England was 1,600 per 100,000 in 1800. With the industrial development, the epidemic traveled to the Midwest in 1840 and to the West in 1880. Though the disease occurred in blacks at a lower rate than in whites before the Civil War, the increase was massive among blacks after the war, when emancipation and urbanization created an ideal atmosphere for transmission of TB. The American Indians and Alaskans were the last American populations to become affected by the TB epidemic.

At the turn of the century it was estimated that 10% of all deaths in the United States were due to TB. By 1904 the TB death rate for the United States was 188, by 1920 the rate was 100 per 100,000, and by 1955 the rate had decreased to less than 10 per 100,000 people per year.

The TB sanatorium movement, which was started in Germany by Dr. Hermann Brehmeris in the 1850s, did not take hold in the United States until after 1884. Edward Livingston Trudeau, a physician who recovered from TB disease, started a sanatorium in Saranac Lake, New York, based on the European model of strict supervision in providing fresh air and sunshine, bed rest, and nutritious foods.

Image 3: Photograph of a small building - "Little Red," first cottage for tuberculosis patients at Trudeau Sanatorium.

As infection control measures took hold in large urban centers of the country, TB patients who could not be treated in local dispensaries were removed from the general population and placed into sanatoriums. Soon a great movement was underway to build TB sanatoriums. By 1938 there were more than 700 sanatoriums throughout the United States, yet the number of patients outnumbered the beds available.

For those households in which the adults could not be placed in a sanatorium, children were removed from infected parents and placed in preventoriums that were created for children.

A milestone in the history of TB control in the United States occurred in the autumn of 1893, when the New York City Board of Health called on Dr. Hermann Michael Biggs, the Chief Inspector of the Division of Pathology, Bacteriology, and Disinfection, for a report on TB. In the report, Biggs stated that TB, which was responsible for more than 6,000 deaths in New York City in 1892, was both communicable and preventable. Some of the recommendations made to the Board in his report were the need to

  1. educate the public of the dangers that the disease posed to the person and his/her contacts,
  2. properly dispose of and immediately destroy sputum or the "discharges from the lungs" of individuals with disease,
  3. have all physicians of pulmonary cases report such cases to the health department,
  4. have health inspectors visit the families where TB exists and deliver proper literature and take specific measures to disinfect the areas as may be required,
  5. obtain and submit sputum specimens to the laboratory for analysis, and
  6. create a consumptive hospital to care for indigent patients.

The Board adopted most of the recommendations made by Biggs, including the creation of "The Consumptive Hospital." These recommendations created a storm of controversy among the medical community. Many private doctors objected to the mandatory reporting, believing that it violated physician-patient confidentiality. Because of the resistance from the medical community, reporting practices were not fully implemented for several years. In the end, Biggs' recommendations to the Board and their implementation in New York City created the model for TB control programs that was emulated by other health departments across the country and laid the groundwork for a campaign called the "War on Consumption."

Image 4: Photograph of patients sitting outside - With no drug therapies, past TB patients like these in 1953 were isolated in sanatoriums.

During the first part of the 20th century, great emphasis was placed on improving social conditions and educating the general public about good hygiene and health habits. If you went to public school anytime between 1900 and 1930, you got the TB message, which said essentially that spit is death. In hospitals it was common to see signs that read "Spit Is Poison." Notices were plainly printed in public places and government buildings that stated "Do Not Spit on the Floor; To Do So May Spread Disease."

In the 1920s, when fresh air and bed rest did not secure improvement in the patient's condition, physicians sometimes performed surgery or collapsed one of the lungs (pneumothorax). During this time there were many other "sure-cure" remedies being advertised by many firms and physicians.

Image 5: Picture of an old advertisement - During the early 1900s, there were many "sure-cure" remedies being advertised by many firms and physicians.

In 1902 at the first International Conference on Tuberculosis held in Paris, Dr. Gilbert Sersiron suggested the adoption of the Cross of Lorraine, used by the Knights of the First Crusade, as the symbol of a new movement, a crusade for good health against sickness and death, and against TB. The double-barred cross was adopted as the international symbol for the fight against TB. This symbol was later adopted in 1904 in the United States by the forerunner of the American Lung Association.

It was not until the turn of the century that private voluntary groups in the United States joined the fight against TB. In April 1892, Dr. Lawrence F. Flick organized the first American voluntary anti-TB organization, the Pennsylvania Society for Prevention of Tuberculosis. The organization was instrumental in helping organize free hospitals for poor consumptive patients in Philadelphia. In 1902, Dr. S. Adolphus Knopf of New York was one of the men responsible for the movement that launched the Committee on the Prevention of Tuberculosis of the Charity Organization Society of New York City. The aim of the committee was to disseminate information that TB was a communicable, preventable, and curable disease. The Committee advanced the movement for hospitals, sanatoriums, and dispensaries for consumptive adults and children. As a result of his focus on the need for a national TB association, in 1904 a voluntary health agency was organized under the National Association for the Study and Prevention of Tuberculosis, later renamed the National Tuberculosis Association (NTA) and now known as the American Lung Association.

To fund the activities of the many local affiliates, the Association adopted a method that was originated in Denmark in 1904 by Einor Holboll, a Danish postal clerk, who sold Christmas Seals. In 1907, many TB sanatoriums had sprung up all around the country; most were small and makeshift. One in Delaware was in such urgent need of funds that it was going to have to close unless $300 could be raised. Dr. Joseph Wales, one of the doctors working at that sanatorium, contacted his cousin, Emily Bissell, to help raise the money. Emily was a welfare worker in Wilmington, Delaware; she was also active in the American Red Cross and had fund-raising experience. After reading an article about the Christmas seals in Denmark, she created a design, borrowed money from friends, and had 50,000 Christmas seals printed. The seals were sold for a penny each at the post office. She worked hard to make the campaign a success, personally presenting the idea to all sorts of groups and officials, including the Philadelphia North American newspaper, emphasizing how buying Christmas seals would help children and adults with TB. The idea took hold, and by the end of the holiday season, $3,000 had been raised 10 times the amount she had set out to raise. By 1946 at least 10 million people were purchasing seals or giving to the Christmas seal fund. The Christmas seal campaign was so widely advertised on buttons, milk caps, postcards, school booklets, billboards, book marks, rail and bus passes, etc., that it permeated many aspects of social life. The National TB Association said at that time that "No nationwide program has rested for so many years on so broad a base made up of millions of small gifts."

Image 6: Photograph of Emily Bissell - Emily Bissell started the U.S. Christmas Seal campaign to raise funds for TB sanatoriums

Then, in the middle of World War II, came the final breakthrough, the greatest challenge to the bacterium that had threatened humanity for thousands of years: chemotherapy.

Image 7: Photo of baseball game promotion - The Christmas seal campaign was so widely advertised that it permeated many aspects of social life.

In fact, the chemotherapy of infectious diseases, using sulfonamide and penicillins, had been underway for several years, but these compounds were ineffective against Mycobac-terium tuberculosis. Since 1914, Selman A. Waksman had been systematically screening soil bacteria and fungi, and at the University of California in 1939 had discovered the marked inhibitory effect of certain fungi, especially actinomycetes, on bacterial growth. In 1940, he and his team were able to isolate an effective anti-TB antibiotic, actinomycin; however, this proved to be too toxic for use in humans or animals.

Success came in 1943. In test animals, streptomycin, purified from Streptomyces griseus, combined maximal inhibition of M. tuberculosis with relatively low toxicity. On November 20, 1944, the antibiotic was administered for the first time to a critically ill TB patient. The effect was almost immediate and impressive. His advanced disease was visibly arrested, the bacteria disappeared from his sputum, and he made a rapid recovery. The new drug had side effects especially on the inner ear but the fact remained, M. tuberculosis was no longer a bacteriological exception; it could be assailed and beaten into retreat within the human body.

A rapid succession of anti-TB drugs appeared in the following years. These were important because with streptomycin monotherapy, resistant mutants began to appear within a few months, endangering the success of antibiotic therapy. However, it was soon demonstrated that this problem could be overcome with the combination of two or three drugs.

Although there were some attempts at providing guidance on TB control measures through publication and conferences, the federal control of TB did not occur until the mid-1940s, when the 1944 Public Health Service Act (Public Law 78-410) authorized the establishment of a TB control program. On July 6, 1944, the Surgeon General established a Tuberculosis Control Division in the Bureau of State Services of the Public Health Service (PHS). Doctor Herman E. Hilleboe was appointed medical director of the new division. The Public Health Service provided supplemental fiscal support to state and local health departments for TB control activities through formula grants and special grants-in-aid. These grants were to assist states in establishing and maintaining adequate measures for prevention, treatment, and control of TB and focused greater attention on the need for case finding.

In 1947, the PHS organized and supported mass x-ray screening in communities with populations greater than 100,000. Over a period of 6 years more than 20 million people were examined; the program ended in 1953. The mobile x-ray vans continued to be used in the communities into the mid-1960s. It was common use to show well-known figures such as Santa Claus posing for x-ray pictures, stimulating the population's compliance with being tested.

Image 8: Photograph of Santa Claus - In 1947, the U.S. organized mass x-ray screening campaigns in large cities; it was common to show well-known figures such as Santa Claus posing for x-rays.

A new era was advancing with the introduction of TB drugs, resulting in a declining morbidity. The mainstreaming of TB treatment to general hospitals and local community clinics reduced the need for and dependency on sanatoriums. In 1959 at the Arden House Conference, sponsored by the National Tuberculosis Association and the U.S. Public Health Service, recommendations were made for mobilizing community resources and applying the widespread use of chemotherapy as a public health measure along with other case-finding activities under the control of public health authorities. With the natural decline in disease and the introduction of chemotherapy in the 1940s and 1950s, TB disease started to take on a dramatic decline in the United States. Morbidity declined at a rate of about 5% per year until 1985, when 22,201 cases were reported in the U.S. for a case rate of 9.3 per 100,000 population. By 1970, only a handful of sanatoriums still remained in the United States and by 1992 there were only four TB hospitals with 420 beds providing care.

Between 1953 and 1979, along with the declining morbidity came declining funding from state, local, and federal agencies responsible for TB control. The cutback in TB control programs across the country left a dismantled and frail public health infrastructure, too weak to ward off the emergence of a new epidemic wave that was brewing. Little did the experts know that a new illness that was first observed among gay men in New York City and San Francisco (HIV/AIDS) would have a dramatic impact on TB morbidity.

The mid-1980s and early 1990s saw an increase in TB morbidity. It was not long before the country started to see TB and HIV coinfections as well as cases with multidrug resistance. Facilities with poor or no infection control measures experienced numerous nosocomial outbreaks, and there were high death rates in hospital wards and correctional facilities throughout the country.

The unprecedented media coverage of TB, a disease barely noticed for more than 20 years, gave rise to increased funding by state, local, and federal agencies for TB control activities. With the infusion of funds came the task of rebuilding a national infrastructure to control TB and the introduction to TB control programs of a concept that was old, yet new: that of directly observed therapy (DOT), in which the TB patients ingest or take their therapy in the presence of a health care worker.

Image 9: Cover of Newsweek - The unprecedented media coverage of TB gave rise to increased funding for TB control activities.

As the numbers of TB cases continue to decline in the United States, nearly half of the new cases reported are occurring in people who have immigrated to the United States. In 1998, of the 18,361 cases reported in the United States, 7,591 or 41.3% occurred in foreign-born persons. Most of these persons came to the United States from countries where TB is still endemic (e.g., Mexico, the Philippines, Viet Nam, China, and India). While the United States continues to bring its TB problem under control, it must be realized that the United States is not an island unto itself, isolated from the rest of the global community.

In 1993, the World Health Organization declared TB a global emergency. Approximately 8 million new cases and 2-3 million deaths occur each year around the world from TB. In an effort to reduce TB morbidity and mortality worldwide, we must share our expertise, successes, and failures, if we are to move toward national and global TB elimination.

We have the power to relegate this ancient enemy to the confinement of laboratory vials and store it in a deep freeze. As we journey into a new century and a new millennium, we will face new opportunities and challenges and write new chapters in the history of TB. Will we learn from the past? Will we develop and use new technology to the utmost efficiency? Will we utilize our resources prudently, and share information with our neighbors? Will we devote our energies and talents to the elimination of our common enemy? How long will it take us to accomplish our goals? How many more lives will be sacrificed to TB? The answer to those questions rests in each of us who works in TB control.

In 1956, the Minnesota Tuberculosis and Health Association encouraged school children to be Knights of the Double-Barred Cross and to pledge "…to do everything…to overthrow the enemy, TB." Are we willing to take the same pledge today?

 


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination - http://www.cdc.gov/tb

Please send comments/suggestions/requests to: hsttbwebteam@cdc.gov, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333